4//SEC Filing
Eiger BioPharmaceuticals, Inc. 4
Accession 0001209191-16-138022
CIK 0001305253operating
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 6:52 PM ET
Size
7.7 KB
Accession
0001209191-16-138022
Insider Transaction Report
Form 4
Shaffer James P
Chief Business Officer
Transactions
- Purchase
Common Stock
2016-08-18$15.70/sh+3,125$49,063→ 5,620 total
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeoperating
Related Parties
1- filerCIK 0001305253
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 6:52 PM ET
- Size
- 7.7 KB